首页> 美国卫生研究院文献>other >Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
【2h】

Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery

机译:高渗盐水对上消化道手术患者术后并发症的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to explore the impact of 3% hypertonic saline (HS) intragastric administration for patients who underwent upper gastrointestinal surgery.During the postoperative period, 3% HS has been suggested as a means to improve the intestinal edema and reduce gastrointestinal complications.The medical records of 111 patients with HS intragastric administration following upper gastrointestinal surgery and 268 patients, served as control, were reviewed retrospectively. Propensity score matching was performed to adjust for selected baseline variables. Clinical outcomes, including early gastrointestinal function recovery, postoperative complications, and length of hospital stay, were compared according to the HS intragastric administration or not.HS intragastric administration was associated with prompt postoperative gastrointestinal function recovery, including first flatus (risk ratio [RR], 1.32; 95% confidence interval [CI], 0.89–1.65; P = 0.048) and feeding within 3 postoperative days (RR (95% CI), 0.57 (0.49–0.77); P = 0.036). Early ileus occurred in 25 of 108 patients with HS treatment versus 36 of 108 patients without HS treatment (RR (95% CI), 1.43 (0.63–2.15); P = 0.065). The patients with HS experienced a lower overall postoperative complication (odds ratio [OD] 0.57; 95% CI, 0.33–1.09; P = 0.063), including trend toward a decrease for infectious complications (15[13.9] vs 23[21.3]; P = 0.11; OD, 0.59; 95% CI, 0.29–1.22). There was a decreased incidence of anastomotic leakage (1[0.9] vs 7[6.5]; P = 0.033) and postoperative ileuas (5[4.6%] vs 11[10.2%]; P = 0.096) in the HS administration patients.Our study demonstrated beneficial postoperative clinical effects of HS intragastric administration in patients who had undergone upper gastrointestinal surgery, such as prompt postoperative gastrointestinal function recovery and reduced overall postoperative complications, which may be attributed to a reduced intestinal edema.
机译:这项研究的目的是探讨3%高渗盐水(HS)胃内给药对上消化道手术患者的影响。在术后期间,建议3%HS作为改善肠水肿和减少胃肠道的手段回顾性分析111例上消化道手术后HS胃内给药的患者和268例患者的病历。进行倾向得分匹配以调整所选基线变量。根据是否进行HS胃内给药比较了包括早期胃肠功能恢复,术后并发症和住院时间在内的临床结局。HS胃内给药与术后胃肠功能迅速恢复相关,包括首次肠胃气胀(风险比[RR] ,1.32; 95%置信区间[CI],0.89–1.65; P = 0.048),术后3天内进食(RR(95%CI),0.57(0.49-0.77); P = 0.036)。 108例接受HS治疗的患者中有25例发生早期肠梗阻,而108例未接受HS治疗的患者中有36例发生早肠梗阻(RR(95%CI),1.43(0.63-2.15); P = 0.065)。 HS患者术后总体并发症较低(几率[OD]为0.57; 95%CI为0.33–1.09; P = 0.063),包括感染并发症发生率呈下降趋势(15 [13.9]比23 [21.3]; P <0.05)。 P = 0.11; OD,0.59; 95%CI,0.29-1.22)。 HS给药患者的吻合口漏发生率(1 [0.9]对7 [6.5]; P = 0.033)和术后肠梗阻发生率降低(5 [4.6%]对11 [10.2%]; P = 0.096)。研究表明,HS胃内给药对上消化道手术患者具有良好的术后临床效果,如术后胃肠功能迅速恢复和术后总体并发症减少,这可能归因于肠道水肿的减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号